Literature DB >> 25331303

Neutrophil-to-lymphocyte ratio as a sensitive marker in diagnosis of celiac disease.

Murat Sarikaya1, Zeynal Dogan1, Bilal Ergul1, Levent Filik1.   

Abstract

Entities:  

Year:  2014        PMID: 25331303      PMCID: PMC4188954     

Source DB:  PubMed          Journal:  Ann Gastroenterol        ISSN: 1108-7471


× No keyword cloud information.
Celiac disease (CD) is a small intestinal mucosal disease leading to malabsorbtion due to inflammatory reaction to gluten [1-4]. CD has a prevelance of approximately 1% of the population. But, it is estimated that up to 90% are undiagnosed due to subclinical presentations [5]. Also, diverse clinical manifestations can lead to delays in diagnosis [4]. Laboratory indices and biomarkers used in daily general medical practice are important in detecting new cases of CD, otherwise a delayed diagnosis can lead to development of important complications such as osteoporosis [6-9]. Neutrophil-to-lymphocyte ratio (NLR) was introduced as a useful index for diagnosis or prognosis of different diseases [7]. We hypothesized that NLR might change in patients with CD as an inflammatory disease. Blood count changes such as anemia, leukopenia are well-known but there is no data for NLR in CD [8,9]. In this regard, we prospectively checked the diagnostic role of the NLR in 76 patients with CD (M:26, F:50) at the time of diagnosis. Diagnosis of study patients was based on celiac antibodies (anti-gliadin, anti-endomysium and tissue transglutaminase), and duodenal biopsy [1,10]. Eighty-six patients with functional dyspepsia (M:33, F:53), all of whom had a normal complete blood cell count, C-reactive protein (CRP), and negative serology for anti-gliadin and anti-endomysium antibodies were recruited as control group. Statistical analyses were performed using SPSS version 17.0. Chi-square test was used for comparison of categorical variables. A P-value <0.05 was considered statistically significant. The Receiver Operating Characteristics (ROC) curve analysis was carried out to indicate the sensivity and specifity of NLR and its respective optimal cut-off value for predicting CD. Mean ages of groups were 38.5±12.11 years in CD patients and 36.5±12.2 years in controls (P>0.05). NLR was significantly higher in patients with CD (2.42±1.24) when compared to control group (1.92±0.58) (P<0.019). The success of NLR in diagnosing CD was statistically remarkable when tested with ROC analysis (Fig. 1). The cut-off value of NLR was 2.32. According to this cut-off value, sensitivity was 80% and specificity 41%.
Figure 1

The receiver-operating characteristic curve of neutrophil-to- lymphocyte ratio for predicting celiac disease

The receiver-operating characteristic curve of neutrophil-to- lymphocyte ratio for predicting celiac disease Neutrophils and lymphocytes are the cells that play a major role in inflammatory processes. Therefore, counts of neutrophils and lymphocytes temporarily change in inflammation. Cellular immunity obviously plays a major role in intestinal damage in CD [1,2,8]. The main pathogenesis of CD is believed to be related to a gluten-specific T-lymphocyte-mediated response resulting in an overexpression of interferon-γ in the epithelial compartment [1]. Inflammation is not confined to duodenum but also involves other gastrointestinal mucosa. Accordingly, surface lymphocytic infiltration of the stomach and colon can also be seen [9]. NLR change seems to be linked with this inflammation and cytokines. In conclusion, NLR might be used as a sensitive laboratory index in screening and diagnosis of CD.
  10 in total

1.  Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice.

Authors:  K Rostami; J Kerckhaert; R Tiemessen; B M von Blomberg; J W Meijer; C J Mulder
Journal:  Am J Gastroenterol       Date:  1999-04       Impact factor: 10.864

Review 2.  Hematologic manifestations of celiac disease.

Authors:  Thorvardur R Halfdanarson; Mark R Litzow; Joseph A Murray
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

Review 3.  Gluten-free diet: the medical and nutrition management of celiac disease.

Authors:  Jacalyn See; Joseph A Murray
Journal:  Nutr Clin Pract       Date:  2006-02       Impact factor: 3.080

4.  Increasing prevalence of coeliac disease over time.

Authors:  S Lohi; K Mustalahti; K Kaukinen; K Laurila; P Collin; H Rissanen; O Lohi; E Bravi; M Gasparin; A Reunanen; M Mäki
Journal:  Aliment Pharmacol Ther       Date:  2007-11-01       Impact factor: 8.171

5.  Sensitivity of serum tissue transglutaminase antibodies for endomysial antibody positive and negative coeliac disease.

Authors:  W Dickey; S A McMillan; D F Hughes
Journal:  Scand J Gastroenterol       Date:  2001-05       Impact factor: 2.423

Review 6.  Recent advances in coeliac disease.

Authors:  Paul J Ciclitira
Journal:  Clin Med (Lond)       Date:  2003 Mar-Apr       Impact factor: 2.659

7.  ACG clinical guidelines: diagnosis and management of celiac disease.

Authors:  Alberto Rubio-Tapia; Ivor D Hill; Ciarán P Kelly; Audrey H Calderwood; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2013-04-23       Impact factor: 10.864

8.  Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment.

Authors:  Takashi Motomura; Ken Shirabe; Yohei Mano; Jun Muto; Takeo Toshima; Yuichiro Umemoto; Takasuke Fukuhara; Hideaki Uchiyama; Toru Ikegami; Tomoharu Yoshizumi; Yuji Soejima; Yoshihiko Maehara
Journal:  J Hepatol       Date:  2012-08-25       Impact factor: 25.083

9.  Increased prevalence and mortality in undiagnosed celiac disease.

Authors:  Alberto Rubio-Tapia; Robert A Kyle; Edward L Kaplan; Dwight R Johnson; William Page; Frederick Erdtmann; Tricia L Brantner; W Ray Kim; Tara K Phelps; Brian D Lahr; Alan R Zinsmeister; L Joseph Melton; Joseph A Murray
Journal:  Gastroenterology       Date:  2009-04-10       Impact factor: 22.682

10.  Studies of intestinal lymphoid tissue. XI--The immunopathology of cell-mediated reactions in gluten sensitivity and other enteropathies.

Authors:  M N Marsh
Journal:  Scanning Microsc       Date:  1988-09
  10 in total
  6 in total

1.  Ratio of spleen diameter to red blood cell distribution width: a novel indicator for celiac disease.

Authors:  Daniel Vasile Balaban; Alina Popp; Andrei Marian Lungu; Raluca Simona Costache; Ioana Alina Anca; Mariana Jinga
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

Review 2.  The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies - A Narrative Review.

Authors:  Paulina Stefaniuk; Agnieszka Szymczyk; Monika Podhorecka
Journal:  Cancer Manag Res       Date:  2020-04-29       Impact factor: 3.989

Review 3.  Bone Fragility in Gastrointestinal Disorders.

Authors:  Daniela Merlotti; Christian Mingiano; Roberto Valenti; Guido Cavati; Marco Calabrese; Filippo Pirrotta; Simone Bianciardi; Alberto Palazzuoli; Luigi Gennari
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

4.  Neutrophil-to-lymphocyte ratio as a predictor of clinical outcomes in critically ill COVID-19 patients: A retrospective observational study.

Authors:  Husain S Ali; Dore C Ananthegowda; Ebrahim M A Ebrahim; Nevin Kannappilly; Mohammad Al Wraidat; Ahmed S Mohamed; Mohamad Y Khatib
Journal:  Health Sci Rep       Date:  2022-09-15

5.  Causes of variation in the neutrophil-lymphocyte and platelet-lymphocyte ratios: a twin-family study.

Authors:  Bochao D Lin; Jouke-Jan Hottenga; Abdel Abdellaoui; Conor V Dolan; Eco J C de Geus; Cornelis Kluft; Dorret I Boomsma; Gonneke Willemsen
Journal:  Biomark Med       Date:  2016-10-03       Impact factor: 2.851

6.  Chocolate Consumers and Lymphocyte-to-Monocyte Ratio: A Working Hypothesis from a Preliminary Report of a Pilot Study in Celiac Subjects.

Authors:  Anna Raguzzini; Giovanna Poce; Sara Consalvi; Elisabetta Toti; Francesca Palmacci; Mariangela Biava; Ilaria Peluso
Journal:  Antioxidants (Basel)       Date:  2019-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.